Podcast sponsor
Sirtris Pharmaceuticals (NASDAQ:SIRT) is a biopharmaceutical company focused on discovering and dveloping propriety, orally available, small molecule drugs with the potential to treat diseases associated with ageing, including metabolic diseases such as Type 2 Diabetes. Our drug candidates are designed to mimic certain beneficial health effects of calorie restriction, without requiring a change in eating habits. They do this by activating SIRT1, a member of a recently discovered class of enzymes calles sirtuins, which control the ageing process. Our most advanced programs are focused on developing activators of SIRT1 and include SRT501, our proprietary formulation of resveratrol, a natural substance found in red wine and other plant products. We are confident that drug development targeting sirtuins has the potential to address a broad range of diseases of ageing, such as metabolic and mitichondrial disorders like Type 2 Diabetes, as well as cancer and neurological disorders.
For more information, please visit www.sirtrispharma.com.
Top of page
